United Kingdom



BRIEF-Zealand Pharma Q2 operating loss widening to DKK 88.0 million

* Q2 operating loss 88.0 million Danish crowns ($13.33 million) versus loss 64.6 million crowns year ago

7:08am BST

BRIEF-Recipharm invests 3.7 mln euros in Italy

* Says the 3.7 mln euro investment forms part of Recipharm's strategy to become leading lyophilisation provider.

7:00am BST

BRIEF-Agfa Gevaert Q2 net profit up 60% to 40 million euros

* Q2 revenue 645 million euros ($727.11 million) versus 691 million euros year ago

6:52am BST

BRIEF-Weifa Q2 adjusted EBITDA rises to NOK 18.6 million

* Record second-quarter revenues of 95.3 million Norwegian crowns ($11.6 million), a total increase of 35 pct - organic growth of 17 pct (excluding Asan)

6:48am BST

BRIEF-Veloxis Pharmaceuticals Q2 operating loss widens to $9.6 million

* Said on Wednesdays Q2 revenue $1.8 million versus $783,000 year ago

6:33am BST
GlaxoSmithKline PLC 1,658.50p --
AstraZeneca PLC 5,080.00p --
Shire PLC 5,025.00p --


  • Sectors
  • Europe
  • U.S.
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.